Orphapacket:
  AverageAgeOfDeaths:
    AverageAgeOfDeath:
    - value: No data available
  AverageAgeOfOnsets:
  - AverageAgeOfOnset:
      value: Adolescent
  - AverageAgeOfOnset:
      value: Childhood
  DisorderType:
    PURL: http://www.orpha.net/ORDO/Orphanet_377788
    value: Disease
  ExternalReferences:
  - DisorderMappingRelation: NTBT (ORPHA code's Narrower Term maps to a Broader Term)
    Reference: '612319'
    Source: OMIM
  Genes:
  - Gene:
      ExternalReferences: []
      Name: fatty acid 2-hydroxylase
      Symbol: FA2H
  Label: Fatty acid hydroxylase-associated neurodegeneration
  ORPHAcode: '329308'
  ORPHApacketId: '329308'
  PURL: http://www.orpha.net/ORDO/Orphanet_329308
  Parents:
  - Parent:
    - Label: Neurodegeneration with brain iron accumulation
      ORPHAcode: '385'
  - Parent:
    - Label: Autosomal recessive complex spastic paraplegia
      ORPHAcode: '100981'
  - Parent:
    - Label: Disorder of phospholipids, sphingolipids and fatty acids biosynthesis
        with central nervous system predominant involvement
      ORPHAcode: '352306'
  - Parent:
    - Label: Syndromic hereditary optic neuropathy
      ORPHAcode: '441434'
  Phenotypes:
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0007020
      HPOTerm: Progressive spastic paraplegia
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0002478
      HPOTerm: Progressive spastic quadriplegia
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0002493
      HPOTerm: Upper motor neuron dysfunction
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0007153
      HPOTerm: Progressive extrapyramidal movement disorder
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0007325
      HPOTerm: Generalized dystonia
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0007240
      HPOTerm: Progressive gait ataxia
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0001260
      HPOTerm: Dysarthria
  - Phenotype:
      HPOFrequency: Very rare (<4-1%)
      HPOId: HP:0002015
      HPOTerm: Dysphagia
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0000648
      HPOTerm: Optic atrophy
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0007924
      HPOTerm: Slow decrease in visual acuity
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0001123
      HPOTerm: Visual field defect
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0030584
      HPOTerm: Color vision test abnormality
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0000486
      HPOTerm: Strabismus
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0000666
      HPOTerm: Horizontal nystagmus
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0000605
      HPOTerm: Supranuclear gaze palsy
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0040168
      HPOTerm: Focal seizures, afebril
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0001272
      HPOTerm: Cerebellar atrophy
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0006855
      HPOTerm: Cerebellar vermis atrophy
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0006827
      HPOTerm: Atrophy of the spinal cord
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0002079
      HPOTerm: Hypoplasia of the corpus callosum
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0001268
      HPOTerm: Mental deterioration
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0002505
      HPOTerm: Progressive inability to walk
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0002527
      HPOTerm: Falls
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0007199
      HPOTerm: Progressive spastic paraparesis
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0006957
      HPOTerm: Loss of ability to walk
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0002425
      HPOTerm: Anarthria
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0002427
      HPOTerm: Motor aphasia
  - Phenotype:
      HPOFrequency: Very rare (<4-1%)
      HPOId: HP:0009830
      HPOTerm: Peripheral neuropathy
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0002069
      HPOTerm: Bilateral tonic-clonic seizure
  - Phenotype:
      HPOFrequency: Very rare (<4-1%)
      HPOId: HP:0000739
      HPOTerm: Anxiety
  - Phenotype:
      HPOFrequency: Very rare (<4-1%)
      HPOId: HP:0000716
      HPOTerm: Depression
  - Phenotype:
      HPOFrequency: Very rare (<4-1%)
      HPOId: HP:0007302
      HPOTerm: Bipolar affective disorder
  Prevalences:
    Prevalence:
    - PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Worldwide
      PrevalenceQualification: Class only
      PrevalenceType: Point prevalence
      Source: ORPHANET_21735565[PMID]
      ValMoy: '0.0'
  Synonyms:
  - Synonym: FAHN
  TextSection:
    Contents: Fatty acid hydroxylase-associated neurodegeneration (FAHN) is a very
      rare autosomal recessive form of neurodegeneration with brain iron accumulation
      (NBIA) characterized by childhood-onset focal dystonia progressive spastic paraplegia
      that progresses to tetra paresis ataxia dysarthria intellectual decline and
      oculomotor disturbances (optic atrophy) accompanied by iron deposition in the
      globus pallidus.
    TextSectionType: Definition
  copyright: Orphanet (c) 2022
  creationDate: '2022-11-28 11:04:13'
  version: 1.3.18 / 4.1.7 [2022-07-12] (orientdb version)
